Drug Delivery Leadership: Recruiting Executives for Combination Products, Scale-Up and Lifecycle Strategy

Why Drug Delivery Leadership Requires a Broader Executive Skill Set

Drug delivery programs sit at the intersection of pharmaceutical science, device engineering, patient usability, manufacturing, and regulatory compliance. A formulation decision may affect device performance. A device design may influence assembly requirements, packaging, or distribution. A manufacturing change may require additional verification, documentation, or regulatory assessment.

These dependencies make leadership experience across the product lifecycle particularly valuable. Executives must understand the implications of decisions beyond their immediate technical function and establish processes for resolving competing priorities.

For example, a development team may favor a delivery platform because it meets laboratory performance requirements. Manufacturing may identify assembly constraints, while quality teams raise concerns about process controls and commercial leaders request a simpler patient experience. A capable executive creates a structured decision process that evaluates these considerations together rather than allowing each function to optimize independently.

Organizations should therefore assess candidates on three dimensions: technical credibility, cross-functional leadership, and the ability to translate product strategy into reliable execution.

Recruiting Executives for Combination Product Complexity

Combination products introduce coordination challenges because their drug and device elements must work together as an integrated product. Depending on the product, leadership responsibilities may include formulation compatibility, device performance, design controls, human factors, risk management, packaging, quality systems, and regulatory planning.

Evaluate integration experience, not just technical specialization

A candidate may have deep expertise in pharmaceutical development or medical device engineering without having led an integrated combination product program. Hiring teams should distinguish between contributing to one technical workstream and owning decisions across the broader development process.

Useful interview questions include:

• Which drug-device integration decisions has the candidate personally led?
• How did the candidate manage conflicting requirements between formulation, device design, usability, and manufacturing?
• How were technical risks identified, escalated, and resolved?
• What role did the candidate play in design reviews, verification, validation, and regulatory readiness?
• How did the candidate coordinate internal teams, contract manufacturers, device suppliers, and other external partners?

Ask candidates to explain a specific program, their individual responsibilities, the alternatives considered, and the reasoning behind major decisions. This helps separate practical leadership experience from familiarity with industry terminology.

Assess regulatory and quality judgment

Executives responsible for combination products do not need to replace specialist regulatory or quality professionals. They do need to understand when those experts must be involved and how regulatory, quality, and technical requirements influence business decisions.

Strong candidates can describe how they integrate regulatory strategy, risk management, documentation, design controls, and quality oversight into development planning. They should also recognize that requirements depend on the product, intended use, markets, and applicable regulatory framework.

During interviews, explore how candidates have handled changing requirements, incomplete evidence, design modifications, supplier issues, or disagreements over readiness. Their responses can reveal whether they treat quality and compliance as integral to execution or as late-stage approval activities.

Finding Leaders Who Can Deliver Manufacturing Scale-Up

Moving a drug delivery product from development into commercial manufacturing requires more than increasing production volume. The organization must establish repeatable processes, appropriate controls, dependable suppliers, effective technology transfer, and a manufacturing model that supports expected demand.

Scale-up can expose issues that were less visible during early development. Equipment capabilities may differ from laboratory assumptions. Assembly processes may introduce variability. Component availability, production yields, packaging requirements, and quality procedures may affect launch readiness.

Look for evidence of development-to-manufacturing execution

When recruiting operations, technical operations, engineering, or drug delivery executives, examine their involvement in:

• Technology transfer from development teams to manufacturing sites or external partners.
• Process development, equipment selection, qualification, and validation planning where applicable.
• Supplier qualification, component controls, and supply continuity.
• Manufacturing readiness reviews and cross-functional risk assessments.
• Investigation of process variability, yield issues, and recurring quality problems.
• Coordination between production capacity, product demand, and launch timelines.

Ask candidates to describe a scale-up challenge they managed and how they determined the appropriate response. Strong leaders explain the evidence behind their decisions, the functions involved, the risks they prioritized, and how they measured whether corrective actions worked.

It is also important to clarify the scale-up environment. Experience at a large, established manufacturer may not translate directly to a smaller biotechnology company building its operating model. Conversely, a leader who has built a flexible development organization may need additional support when moving into a highly standardized, high-volume manufacturing environment.

Test the candidate’s approach to external manufacturing partners

Many organizations depend on contract development and manufacturing organizations, device manufacturers, component suppliers, or specialist engineering partners. Executives must be able to define responsibilities, establish governance, evaluate partner capabilities, and resolve issues without creating unnecessary friction.

Hiring teams should explore how candidates establish performance expectations, manage technical transfers, escalate quality concerns, and maintain visibility into supplier risks. The objective is to identify leaders who can create accountability across organizational boundaries while protecting product quality and program continuity.

Lifecycle Strategy: Leadership Beyond Product Launch

Commercial launch is an important milestone, but it is not the end of a drug delivery executive’s responsibilities. Products may require post-market monitoring, manufacturing improvements, supplier changes, device updates, packaging revisions, new market registrations, or adaptations to changing patient and business needs.

Lifecycle strategy connects these decisions to the product’s long-term performance. Without clear ownership, organizations can become reactive, addressing individual issues without understanding their broader implications for quality, cost, supply, regulatory commitments, or the product portfolio.

Assess how candidates prioritize lifecycle decisions

Effective leaders establish a structured process for evaluating proposed changes. They consider the reason for the change, the potential effect on product performance, applicable regulatory requirements, implementation risk, manufacturing implications, and communication needs.

Interview candidates about their experience with:

• Post-market quality signals, complaints, and corrective or preventive actions.
• Product and process improvements after commercialization.
• Supplier substitutions, component changes, and manufacturing transfers.
• Change control and assessment of potential regulatory impact.
• Portfolio prioritization across new development programs and established products.
• Long-term product support, supply resilience, and obsolescence planning.

The strongest candidates recognize that lifecycle decisions involve trade-offs. A component change might improve supply availability but require extensive evaluation. A design enhancement might improve usability but introduce new validation or implementation requirements. Leaders must determine how to assess these options systematically and involve the appropriate technical, quality, regulatory, and commercial stakeholders.

Which Executive Roles Should Organizations Prioritize?

The appropriate leadership appointment depends on the organization’s product portfolio, development stage, operating model, and most significant execution risks. A company developing its first combination product may need a different profile from a manufacturer managing multiple commercial delivery platforms.

Head of Drug Delivery or Drug Delivery Development

This leader typically connects delivery technology choices with formulation needs, device requirements, development priorities, and product strategy. The role is especially relevant when an organization needs stronger ownership of delivery-system architecture and cross-functional development decisions.

Vice President of Engineering or Device Development

This executive may be appropriate when device performance, design controls, human factors, verification, validation, or platform development are central challenges. Candidates should also demonstrate an understanding of how engineering decisions affect drug development and manufacturing readiness.

Technical Operations or Manufacturing Leadership

When the principal challenge is scale-up, technology transfer, manufacturing reliability, or supply continuity, organizations may need an executive with substantial technical operations experience. The ideal candidate can connect process capability, quality performance, partner oversight, and production strategy.

Combination Product or Program Leadership

Some organizations need a leader who coordinates multiple functions rather than owning a single technical discipline. This role can be valuable when accountability is fragmented across pharmaceutical development, device engineering, regulatory affairs, quality, and external suppliers.

Before opening a search, executive teams should define decision rights clearly. They should establish which responsibilities sit with the role, which remain with functional specialists, and how major technical or commercial decisions will be escalated.

How to Build a More Effective Executive Hiring Process

Recruiting for drug delivery leadership becomes more effective when the hiring process reflects the real demands of the position instead of relying on a generic executive job description.

1. Define the business problem first

Identify the outcome the hire must deliver. The priority might be progressing a combination product toward commercialization, improving scale-up execution, strengthening lifecycle governance, or coordinating a complex external manufacturing network. Define the first-year outcomes before deciding which candidate backgrounds are essential.

2. Separate essential experience from preferred credentials

Distinguish between capabilities the executive must bring on day one and expertise that can be supplied by the existing team. Requiring every candidate to possess deep formulation, device engineering, regulatory, manufacturing, and commercial experience may unnecessarily narrow the search. Prioritize the combination of expertise and leadership judgment that best fits the business need.

3. Use structured, evidence-based interviews

Ask candidates consistent questions tied to the role’s key responsibilities. Use examples of past decisions, cross-functional conflicts, scale-up challenges, and lifecycle trade-offs to assess how they think and lead. Where possible, validate individual contributions through references and detailed discussion of outcomes.

4. Evaluate leadership across functions

Technical credibility alone does not guarantee executive effectiveness. Assess communication, talent development, decision-making under uncertainty, conflict resolution, and the ability to create accountability without undermining specialist expertise.

5. Align the offer with the actual mandate

Clarify reporting lines, budget authority, team structure, partner responsibilities, decision rights, and near-term expectations before finalizing the appointment. A strong candidate may struggle if the organization expects end-to-end accountability but has not provided the authority or resources required to deliver.

Common Hiring Mistakes to Avoid

Several recurring hiring mistakes can leave drug delivery organizations with leadership gaps even after an apparently successful recruitment process.

• Hiring for technical depth alone: A specialist may be highly capable but lack the cross-functional judgment required to lead an integrated program.
• Overvaluing launch experience: A candidate who has supported commercialization may not have personally led scale-up decisions, partner governance, or manufacturing readiness.
• Underestimating lifecycle responsibilities: Leaders focused exclusively on development milestones may overlook post-market quality, change control, and long-term product support.
• Using an overly broad job specification: Combining unrelated responsibilities can make the role difficult to fill and obscure the capabilities that matter most.
• Ignoring organizational context: Candidate experience should be evaluated against the company’s size, product maturity, internal capabilities, and reliance on external partners.

These risks can be reduced by agreeing on the role’s primary mandate before interviewing candidates and using a consistent scorecard to assess technical, operational, strategic, and leadership competencies.

Conclusion: Recruiting Drug Delivery Leaders for Long-Term Performance

Drug delivery leadership requires a combination of technical understanding, cross-functional judgment, manufacturing awareness, and lifecycle thinking. Executives must be able to guide combination product development, prepare programs for scalable production, align internal and external teams, and manage product changes after launch.

The best hiring decisions begin with a clear understanding of the organization’s most important business and technical challenges. By defining the leadership mandate, assessing candidates against real program experience, and aligning authority with accountability, companies can improve their ability to recruit executives who support reliable execution across the product lifecycle.

For organizations navigating complex delivery technologies or preparing combination products for commercialization, a disciplined executive search can help identify leaders whose experience matches the company’s development stage, manufacturing model, and long-term product strategy.

Frequently Asked Questions

What experience should a drug delivery executive have?

Relevant experience may include drug-device integration, formulation and device development, regulatory and quality coordination, manufacturing scale-up, technology transfer, supplier oversight, and lifecycle management. The required mix depends on the role and the organization’s priorities.

Why is combination product experience important when hiring drug delivery leaders?

Combination products require coordination between drug and device requirements. Leaders with relevant experience are better positioned to recognize dependencies, align specialist teams, and manage technical, quality, manufacturing, and regulatory considerations throughout development.

How should employers assess scale-up experience?

Employers should ask candidates to explain their direct involvement in technology transfer, process readiness, manufacturing challenges, supplier coordination, and quality controls. The discussion should establish what the candidate personally owned and how decisions were evaluated.

What is lifecycle strategy in drug delivery?

Lifecycle strategy covers the planning and governance of a product after initial development and launch. It may include product improvements, change control, post-market quality, supplier changes, manufacturing transfers, regulatory impact assessments, and long-term supply planning.

When should a company recruit a dedicated combination product leader?

A dedicated leader may be useful when product complexity spans several functions, accountability is fragmented, or the organization needs stronger coordination across drug development, device engineering, quality, regulatory affairs, and manufacturing. The decision should reflect program complexity and existing internal capabilities.

How can organizations reduce risk when recruiting senior drug delivery executives?

Define the business mandate clearly, prioritize essential competencies, use structured interviews, validate candidate contributions, check relevant references, and ensure the role has the authority and resources needed to deliver its objectives.